Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium
Sonu Bhaskar(New South Wales Department of Health), Antony Walker, Vijay Kumar Chattu(University of Washington), Anil Adisesh(St. Michael's Hospital), Pravin Thomas(University Hospitals Birmingham NHS Foundation Trust), Anupama Ramakanth Pai(National Institute of Mental Health and Neurosciences), A. Riahi(Tunis University), Aarushi Rastogi(UNSW Sydney), Chakrakodi N. Varun(New South Wales Department of Health), Negman Alvarado(National Technological University), Sarah Barsam(New South Wales Department of Health)
Cited by 50
Related Papers
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021
|The Lancet Rheumatology|2023|1.7k
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021
|The Lancet Haematology|2023|674
Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper
|Frontiers in Immunology|2020|519
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging
|Particle and Fibre Toxicology|2010|491